What does bioAffinity Technologies, Inc. (BIAF) do?

bioAffinity Technologies, Inc. (BIAF) is a publicly traded company in the Healthcare sector.

What sector does BIAF operate in?

bioAffinity Technologies, Inc. operates in the Healthcare, specifically within the Services–Commercial Physical & Biological Research industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find BIAF earnings analysis?

AlphaOS publishes an earnings intelligence page for bioAffinity Technologies, Inc. (BIAF) covering results, guidance context, and AI-assisted analysis. See /stocks/BIAF/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BIAF

bioAffinity Technologies, Inc.

Healthcare · Services–Commercial Physical & Biological Research

$6.88Sep 29, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

bioAffinity Technologies, Inc. shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +19% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +19% YoY in Q2 FY2026

Pipeline evidence · 0d ago

BIAF's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BIAF.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BIAF earnings analysis

Reported figures for bioAffinity Technologies, Inc. — research only, not investment advice.

Revenue YoY: +18.9%

Latest Intelligence

Updated September 30, 2026

What happened recently for bioAffinity Technologies, Inc. (BIAF) — events, not interpretation.

Event: Reported Q2 2026 revenue +19% YoY.
Also: Last session September 29, 2026 at $6.88.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

bioAffinity Technologies, Inc. (BIAF)

Healthcare · Services–Commercial Physical & Biological Research

Investment Snapshot above is the primary AlphaOS analysis for bioAffinity Technologies, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Services–Commercial Physical & Biological Research
Market cap:: $55.74M
Revenue:: $1.51M

BIAF earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow bioAffinity Technologies, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.